Fisher Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.2M | Buy |
1,515,991
+151,032
| +11% | +$2.11M | 0.01% | 309 |
|
|
2025
Q1 | $18.6M | Buy |
1,364,959
+572,460
| +72% | +$7.78M | 0.01% | 336 |
|
|
2024
Q4 | $16.2M | Buy |
792,499
+245,168
| +45% | +$5M | 0.01% | 374 |
|
|
2024
Q3 | $15.9M | Buy |
547,331
+69,223
| +14% | +$2.02M | 0.01% | 368 |
|
|
2024
Q2 | $11.1M | Buy |
478,108
+8,939
| +2% | +$208K | ﹤0.01% | 408 |
|
|
2024
Q1 | $9.63M | Buy |
+469,169
| New | +$9.63M | ﹤0.01% | 428 |
|